Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study
- 30 August 2022
- journal article
- research article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 26 (2) , 410-414
Abstract
Background The Rezum system is one of the latest minimally invasive surgical treatments for benign prostatic hyperplasia. Methods We retrospectively reviewed all patients who underwent the Rezum treatment in seven different Italian institutions. A successful urinary outcome was defined as: ≥50% improvement in the IPSS <7, improvement in peak flow ≥50% and/or more than 15 ml/s, ≥1-point improvement in the QoL questionnaire and in the absence of perioperative major complications (AUR, transfusion) or postoperative incontinence. A successful sexual outcome was defined as postoperative (latest follow up consultation) antegrade ejaculation or no variation in ejaculatory function and an increase, or stability or max 1 class reduction, in IIEF-5. Results 262 patients were enrolled with a follow-up period of 11 months (IQR 5–15). No early or late serious adverse events (Clavien III–IV) occurred. Early complications occurred in 39.3% of cases, with 4 cases of clot retention and one case of blood transfusion. Urge incontinence was reported by 6 patients (2.2%). A treatment failure requiring re-intervention occurred in 4 cases (1.5%). The preoperative antegrade ejaculation rate was 56.5%, and after the procedure it increased to 78.2%. The increase of ≥1-point in the QoL was achieved in 92.7% of the cases. Optimal urinary and sexual outcomes were achieved in 52.9% and 87.8%, respectively. Conclusions In our series, water vapor intraprostatic injections seem to be an effective and safe procedure.Keywords
This publication has 29 references indexed in Scilit:
- Lasers versus bipolar technology in the transurethral treatment of benign prostatic enlargement: a systematic review and meta-analysis of comparative studiesWorld Journal of Urology, 2019
- Rezūm Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year Results From Randomized Controlled StudyUrology, 2019
- Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experienceProstate Cancer and Prostatic Diseases, 2017
- Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezūm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasiaResearch and Reports in Urology, 2017
- Drug Adherence and Clinical Outcomes for Patients Under Pharmacological Therapy for Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Population-based Cohort StudyEuropean Urology, 2015
- Role for intravesical prostatic protrusion in lower urinary tract symptom: a fluid structural interaction analysis studyBMC Urology, 2015
- The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostateWorld Journal of Urology, 2010
- [Evaluation of sexual activity after prostatic surgery for benign prostatic hyperplasia assessed by pre-operative and post-operative questionnaire].2005
- Grading of benign prostatic obstruction can predict the outcome of transurethral prostatectomy.1998
- GRADING OF BENIGN PROSTATIC OBSTRUCTION CAN PREDICT THE OUTCOME OF TRANSURETHRAL PROSTATECTOMYJournal of Urology, 1998